title: Vaccination with feline immunodeficiency virus induces CD4 epitope masking by soluble factors.
abstract: Soluble factors are important effector mechanisms to control for lentiviral replication. Vaccination of cats with recombinant outer surface proteins (SU) of the FIV envelope protein in combination with complete Freund adjuvant (CFA) and rabies nucleocapsid (NC) protein led to significantly reduced viral loads [Leutenegger, C.M., Hofmann-Lehmann, R., Holznagel, E., Cuisinier, A.M., Wolfensberger, C., Duquesne, V., Cronier, J., Allenspach, K., Aubert, A., Ossent, P. , Lutz, H., 1998. AIDS Res. Hum. Retroviruses, 14(3) 275-283]. Lymphocytes from vaccinated and non-vaccinated cats were stained with two monoclonal antibodies, Fel7 and CAT30A, directed against the feline CD4 antigen. Peripheral blood lymphocytes from cats vaccinated with the SU glycoprotein, CFA and rabies NC protein showed a significantly reduced number of cells after staining with CAT30A, while the number in Fel7 positive lymphocytes remained unchanged. This decreased CAT30A fluorescent staining could be reproduced in vitro by pre-incubating FIV-negative lymphocytes with immune sera from cats in which reduced CAT30A staining was detected. Neither experimental infection nor vaccination with the unglycosylated SU protein alone resulted in this epitope masking. Furthermore, this masking phenomenon was negatively correlated with a decreased susceptibility to activation-induced cell death (AICD). These findings will be discussed based on the current knowledge of CD8(+) T-cell antiviral factors and their involvement in lentiviral infection and/or replication.
authors.affiliation: Clinical Laboratory, Department of Internal Veterinary Medicine, University of Zurich, Zurich, Switzerland. cmleutenegger@ucdavis.edu
authors.forename: C M
authors.initials: CM
authors.lastname: Leutenegger
authors.forename: E
authors.initials: E
authors.lastname: Holznagel
authors.forename: R
authors.initials: R
authors.lastname: Hofmann-Lehmann
authors.forename: A
authors.initials: A
authors.lastname: Aubert
authors.forename: M B
authors.initials: MB
authors.lastname: Tompkins
authors.forename: H
authors.initials: H
authors.lastname: Lutz
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D017209:Apoptosis; D015704:CD4 Antigens / Q000032:analysis*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002415:Cats; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D016181:Feline Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000517:prevention & control; D005260:Female; D005434:Flow Cytometry / Q000662:veterinary; D016089:Immunodeficiency Virus, Feline / Q000276:immunology*; D016130:Immunophenotyping / Q000662:veterinary; D018655:Lymphocyte Count / Q000662:veterinary; D008297:Male; D014611:Vaccination / Q000662:veterinary*; D014614:Vaccines, Synthetic / Q000008:administration & dosage; D014765:Viral Vaccines / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D018984:Epitopes, T-Lymphocyte; D014614:Vaccines, Synthetic; D014765:Viral Vaccines